{"abstracts-retrieval-response": {
    "item": {
        "ait:process-info": {
            "ait:status": {
                "@state": "update",
                "@type": "core",
                "@stage": "S300"
            },
            "ait:date-delivered": {
                "@day": "01",
                "@timestamp": "2022-05-01T10:05:49.000049-04:00",
                "@year": "2022",
                "@month": "05"
            },
            "ait:date-sort": {
                "@day": "01",
                "@year": "2022",
                "@month": "12"
            }
        },
        "xocs:meta": {"xocs:funding-list": {
            "@pui-match": "primary",
            "@has-funding-info": "1",
            "xocs:funding": {
                "xocs:funding-agency-matched-string": "Chulalongkorn University",
                "xocs:funding-agency-acronym": "CU",
                "xocs:funding-agency": "Chulalongkorn University",
                "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/501100002873",
                "xocs:funding-agency-country": "http://sws.geonames.org/1605651/"
            },
            "xocs:funding-addon-generated-timestamp": "2022-03-30T22:55:24.119Z",
            "xocs:funding-text": "The authors are grateful to all participating consumers, community pharmacists, and HPVC employees who participated the interview. We also thank the Faculty of pharmaceutical science, Chulalongkorn University for funding.",
            "xocs:funding-addon-type": "http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/aggregated-refined"
        }},
        "bibrecord": {
            "head": {
                "author-group": [
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "address-part": "254 Phayathai Road, Pathumwan",
                            "postal-code": "10330",
                            "@afid": "60028190",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Faculty of Pharmaceutical Sciences"},
                                {"$": "Chulalongkorn University"}
                            ],
                            "affiliation-id": {
                                "@afid": "60028190",
                                "@dptid": "108180929"
                            },
                            "@affiliation-instance-id": "2015306706-cddb267b78c825108557c57f7f3ce8c4",
                            "ce:source-text": "Faculty of Pharmaceutical Sciences, Chulalongkorn University, 254 Phayathai Road, Pathumwan, Bangkok, 10330, Thailand",
                            "@dptid": "108180929"
                        },
                        "author": [
                            {
                                "ce:given-name": "Tanattha",
                                "preferred-name": {
                                    "ce:given-name": "Tanattha",
                                    "ce:initials": "T.",
                                    "ce:surname": "Kitisopee",
                                    "ce:indexed-name": "Kitisopee T."
                                },
                                "@author-instance-id": "2015306706-98881ecd9ccb57c4aab88efec048dfed",
                                "@seq": "1",
                                "ce:initials": "T.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Kitisopee",
                                "@auid": "54889081900",
                                "@orcid": "0000-0002-5240-8265",
                                "ce:indexed-name": "Kitisopee T."
                            },
                            {
                                "ce:given-name": "Jirunya",
                                "preferred-name": {
                                    "ce:given-name": "Jirunya",
                                    "ce:initials": "J.",
                                    "ce:surname": "Assanee",
                                    "ce:indexed-name": "Assanee J."
                                },
                                "@author-instance-id": "2015306706-9fd0b5946f9d9289d2fc88ca85a529b7",
                                "@seq": "2",
                                "ce:initials": "J.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Assanee",
                                "@auid": "57223977897",
                                "ce:indexed-name": "Assanee J."
                            },
                            {
                                "ce:given-name": "Suntaree",
                                "preferred-name": {
                                    "ce:given-name": "Suntaree",
                                    "ce:initials": "S.",
                                    "ce:surname": "Watcharadmrongkun",
                                    "ce:indexed-name": "Watcharadmrongkun S."
                                },
                                "@author-instance-id": "2015306706-eb2e4c54991a16cb7e617c3aa6dd0f1d",
                                "@seq": "4",
                                "ce:initials": "S.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Watcharadmrongkun",
                                "@auid": "57550027800",
                                "ce:indexed-name": "Watcharadmrongkun S."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "United States",
                            "address-part": "115 South Grand Avenue",
                            "postal-code": "52242",
                            "@afid": "60024324",
                            "@country": "usa",
                            "city": "Iowa City",
                            "organization": [
                                {"$": "College of Pharmacy"},
                                {"$": "The University of Iowa"}
                            ],
                            "affiliation-id": {"@afid": "60024324"},
                            "state": "IA",
                            "@affiliation-instance-id": "2015306706-a12ed764a6459d40bfcf01552e73f6be",
                            "ce:source-text": "College of Pharmacy, The University of Iowa, 115 South Grand Avenue, Iowa City, IA, 52242, USA"
                        },
                        "author": [{
                            "ce:given-name": "Bernard A.",
                            "preferred-name": {
                                "ce:given-name": "Bernard A.",
                                "ce:initials": "B.A.",
                                "ce:surname": "Sorofman",
                                "ce:indexed-name": "Sorofman B.A."
                            },
                            "@author-instance-id": "2015306706-37e82868e626e5ca73a98aa4773eef83",
                            "@seq": "3",
                            "ce:initials": "B.A.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Sorofman",
                            "@auid": "6603710987",
                            "ce:indexed-name": "Sorofman B.A."
                        }]
                    }
                ],
                "citation-title": "Consumers\u2019 adverse drug event reporting via community pharmacists: three stakeholder perception",
                "abstracts": "Â© 2022, The Author(s).Background: Adverse drug event (ADE) reporting is a significant process to increase consumer care and consumer safety associated with the use of medicines. An in-depth investigation into low ADE reporting by consumers and community pharmacists was undertaken to uncover interventions to improve reporting. Method: In-depth interviewing of the three parties; consumers, pharmacists and employees of the Pharmacovigilance Center in Thailand, was used to collect the data. They were interviewed about ADE reporting experiences and contributing factors and problems of ADE reporting. Thematic analysis was used to interpret the results. Result: The HPVC received few ADE reports from consumers. Most community pharmacists received ADE reports from consumers; however, the Pharmacovigilance Center received few ADE reports from community pharmacists. ADE reporting of community pharmacists and consumers were influenced by many factors which were categorized into four themes which were (1) \u201cCognition\u201d (awareness, attitude and responsibility); (2) \u201cReporting process\u201d (complication, competency, information deficiency, feedback, and resource); (3) \u201cInducer\u201d (service orientation, acquaintanceship, motivation, severity level, regulatory and reward); and (4) \u201cObstacle\u201d (doubt, belief and prosecution). Conclusion: Health professionals should motivate consumers to report ADEs. Building social responsibility and benefits and increasing knowledge of reporting process, channels, and system to both community pharmacists and consumers were recommended. Providing rewards and making community pharmacists feel comfortable to report ADEs by simplifying the ADE form and providing training, guidelines, and an ADR assessment tool can drive them to report ADEs. Feedback to consumers by confirming whether it was ADE and feedback to pharmacists that the Pharmacovigilance Center received their reports and their reports were utilized were also important.",
                "correspondence": {
                    "affiliation": {
                        "country": "Thailand",
                        "address-part": "254 Phayathai Road, Pathumwan",
                        "postal-code": "10330",
                        "@country": "tha",
                        "city": "Bangkok",
                        "organization": [
                            {"$": "Faculty of Pharmaceutical Sciences"},
                            {"$": "Chulalongkorn University"}
                        ],
                        "ce:source-text": "Faculty of Pharmaceutical Sciences, Chulalongkorn University, 254 Phayathai Road, Pathumwan, Bangkok, 10330, Thailand"
                    },
                    "person": {
                        "ce:given-name": "Tanattha",
                        "ce:initials": "T.",
                        "ce:surname": "Kitisopee",
                        "ce:indexed-name": "Kitisopee T."
                    }
                },
                "citation-info": {
                    "author-keywords": {"author-keyword": [
                        {
                            "$": "Adverse drug event reporting",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "Community pharmacists",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "Consumers",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "Pharmacovigilance center",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "Stakeholder perception",
                            "@xml:lang": "eng",
                            "@original": "y"
                        }
                    ]},
                    "citation-type": {"@code": "ar"},
                    "citation-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    },
                    "abstract-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    }
                },
                "source": {
                    "website": {"ce:e-address": {
                        "$": "http://www.joppp.org/content",
                        "@type": "email"
                    }},
                    "translated-sourcetitle": {
                        "$": "Journal of Pharmaceutical Policy and Practice",
                        "@xml:lang": "eng"
                    },
                    "volisspag": {"voliss": {
                        "@volume": "15",
                        "@issue": "1"
                    }},
                    "@type": "j",
                    "sourcetitle": "Journal of Pharmaceutical Policy and Practice",
                    "publicationdate": {
                        "month": "12",
                        "year": "2022",
                        "date-text": "December 2022",
                        "day": "01"
                    },
                    "sourcetitle-abbrev": "J. pharm. policy pract.",
                    "@country": "gbr",
                    "issn": {
                        "$": "20523211",
                        "@type": "electronic"
                    },
                    "publicationyear": {"@first": "2022"},
                    "publisher": {"publishername": "BioMed Central Ltd"},
                    "article-number": "19",
                    "@srcid": "21100325142"
                },
                "enhancement": {"classificationgroup": {"classifications": [
                    {
                        "@type": "EMCLASS",
                        "classification": {
                            "classification-code": "17",
                            "classification-description": "Public Health, Social Medicine and Epidemiology"
                        }
                    },
                    {
                        "@type": "ASJC",
                        "classification": [
                            {"$": "3611"},
                            {"$": "3000"},
                            {"$": "2719"}
                        ]
                    },
                    {
                        "@type": "SUBJABBR",
                        "classification": [
                            {"$": "HEAL"},
                            {"$": "PHAR"},
                            {"$": "MEDI"}
                        ]
                    }
                ]}},
                "grantlist": {
                    "@complete": "y",
                    "grant-text": {
                        "$": "The authors are grateful to all participating consumers, community pharmacists, and HPVC employees who participated the interview. We also thank the Faculty of pharmaceutical science, Chulalongkorn University for funding.",
                        "@xml:lang": "eng"
                    }
                }
            },
            "item-info": {
                "copyright": {
                    "$": "Copyright 2022 Elsevier B.V., All rights reserved.",
                    "@type": "Elsevier"
                },
                "dbcollection": [
                    {"$": "EMBASE"},
                    {"$": "REAXYSCAR"},
                    {"$": "RMC"},
                    {"$": "SCOPUS"},
                    {"$": "Scopusbase"}
                ],
                "history": {"date-created": {
                    "@day": "26",
                    "@timestamp": "BST 05:44:56",
                    "@year": "2022",
                    "@month": "04"
                }},
                "itemidlist": {
                    "itemid": [
                        {
                            "$": "2015306706",
                            "@idtype": "PUI"
                        },
                        {
                            "$": "939359565",
                            "@idtype": "CAR-ID"
                        },
                        {
                            "$": "20220276518",
                            "@idtype": "EMBASE"
                        },
                        {
                            "$": "20220988047",
                            "@idtype": "REAXYSCAR"
                        },
                        {
                            "$": "2022156796",
                            "@idtype": "RMC"
                        },
                        {
                            "$": "20221114997",
                            "@idtype": "SCOPUS"
                        },
                        {
                            "$": "20219020046150",
                            "@idtype": "TPA-ID"
                        },
                        {
                            "$": "85127065859",
                            "@idtype": "SCP"
                        },
                        {
                            "$": "85127065859",
                            "@idtype": "SGR"
                        }
                    ],
                    "ce:doi": "10.1186/s40545-022-00417-z"
                }
            },
            "tail": {"bibliography": {
                "@refcount": "24",
                "reference": [
                    {
                        "ref-fulltext": "Schatz S, Weber R. Adverse drug reactions. Pharm Practice. 2015;1:1.",
                        "@id": "1",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Adverse drug reactions"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CR1",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85000350220",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "1"},
                                "pagerange": {"@first": "1"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Schatz",
                                    "ce:indexed-name": "Schatz S."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "R.",
                                    "@_fa": "true",
                                    "ce:surname": "Weber",
                                    "ce:indexed-name": "Weber R."
                                }
                            ]},
                            "ref-sourcetitle": "Pharm Practice"
                        },
                        "ce:source-text": "Schatz S, Weber R. Adverse drug reactions. Pharm Practice. 2015;1:1."
                    },
                    {
                        "ref-fulltext": "HÃ¤rmark L, Van Grootheest A. Pharmacovigilance: methods, recent developments and future perspectives. Eur J Clin Pharmacol. 2008;64(8):743\u201352. DOI: 10.1007/s00228-008-0475-9",
                        "@id": "2",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2008"},
                            "ref-title": {"ref-titletext": "Pharmacovigilance: methods, recent developments and future perspectives"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1007/s00228-008-0475-9",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR2",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "45849119038",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "64",
                                    "@issue": "8"
                                },
                                "pagerange": {
                                    "@first": "743",
                                    "@last": "752"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "L.",
                                    "@_fa": "true",
                                    "ce:surname": "HÃ¤rmark",
                                    "ce:indexed-name": "Harmark L."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Van Grootheest",
                                    "ce:indexed-name": "Van Grootheest A."
                                }
                            ]},
                            "ref-sourcetitle": "Eur J Clin Pharmacol"
                        },
                        "ce:source-text": "HÃ¤rmark L, Van Grootheest A. Pharmacovigilance: methods, recent developments and future perspectives. Eur J Clin Pharmacol. 2008;64(8):743\u201352. DOI: 10.1007/s00228-008-0475-9"
                    },
                    {
                        "ref-fulltext": "World Health Organization, The importance of pharmacovigilance. Vol. 2018. 2002: World Health Organization.",
                        "@id": "3",
                        "ref-info": {
                            "ref-publicationyear": {
                                "@first": "2002",
                                "@last": "2018"
                            },
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CR3",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "1642451400",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-authors": {"collaboration": [
                                {
                                    "@seq": "1",
                                    "ce:text": "World Health Organization",
                                    "ce:indexed-name": "World Health Organization"
                                },
                                {
                                    "@seq": "2",
                                    "ce:text": "World Health Organization.",
                                    "ce:indexed-name": "World Health Organization."
                                }
                            ]},
                            "ref-sourcetitle": "The importance of pharmacovigilance"
                        },
                        "ce:source-text": "World Health Organization, The importance of pharmacovigilance. Vol. 2018. 2002: World Health Organization."
                    },
                    {
                        "ref-fulltext": "World Health Organization, WHO pharmacovigilance indicators: a practical manual for the assessment of pharmacovigilance systems. WHO pharmacovigilance indicators: a practical manual for the assessment of pharmacovigilance systems. 2015: World Health Organization.",
                        "@id": "4",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CR4",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84933540710",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-text": "WHO pharmacovigilance indicators: a practical manual for the assessment of pharmacovigilance systems",
                            "ref-authors": {"collaboration": [
                                {
                                    "@seq": "1",
                                    "ce:text": "World Health Organization",
                                    "ce:indexed-name": "World Health Organization"
                                },
                                {
                                    "@seq": "2",
                                    "ce:text": "World Health Organization.",
                                    "ce:indexed-name": "World Health Organization."
                                }
                            ]},
                            "ref-sourcetitle": "WHO pharmacovigilance indicators: A practical manual for the assessment of pharmacovigilance systems."
                        },
                        "ce:source-text": "World Health Organization, WHO pharmacovigilance indicators: a practical manual for the assessment of pharmacovigilance systems. WHO pharmacovigilance indicators: a practical manual for the assessment of pharmacovigilance systems. 2015: World Health Organization."
                    },
                    {
                        "ref-fulltext": "Suke SG, Kosta P, Negi H. Role of pharmacovigilance in India: An overview. Online J Public Health Inform. 2015;7:2. DOI: 10.5210/ojphi.v7i2.5595",
                        "@id": "5",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Role of pharmacovigilance in India: An overview"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.5210/ojphi.v7i2.5595",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR5",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84962076884",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "7"},
                                "pagerange": {"@first": "2"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "S.G.",
                                    "@_fa": "true",
                                    "ce:surname": "Suke",
                                    "ce:indexed-name": "Suke S.G."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "P.",
                                    "@_fa": "true",
                                    "ce:surname": "Kosta",
                                    "ce:indexed-name": "Kosta P."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "H.",
                                    "@_fa": "true",
                                    "ce:surname": "Negi",
                                    "ce:indexed-name": "Negi H."
                                }
                            ]},
                            "ref-sourcetitle": "Online J Public Health Inform"
                        },
                        "ce:source-text": "Suke SG, Kosta P, Negi H. Role of pharmacovigilance in India: An overview. Online J Public Health Inform. 2015;7:2. DOI: 10.5210/ojphi.v7i2.5595"
                    },
                    {
                        "ref-fulltext": "Heath product vigilance system in Thailand. 2016. http://203.157.72.106/fulltext2/book/17993/1.pdf. Accessed 12 Jan 2018.",
                        "@id": "6",
                        "ref-info": {
                            "ref-website": {"ce:e-address": {
                                "$": "http://203.157.72.106/fulltext2/book/17993/1.pdf",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CR6",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85127075722",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-text": "Accessed 12 Jan 2018",
                            "ref-sourcetitle": "Heath Product Vigilance System in Thailand. 2016"
                        },
                        "ce:source-text": "Heath product vigilance system in Thailand. 2016. http://203.157.72.106/fulltext2/book/17993/1.pdf. Accessed 12 Jan 2018."
                    },
                    {
                        "ref-fulltext": "Hughes ML, Weiss M. Adverse drug reaction reporting by community pharmacists\u2014the barriers and facilitators. Pharmacoepidemiol Drug Saf. 2019;28(12):1552\u20139. DOI: 10.1002/pds.4800",
                        "@id": "7",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Adverse drug reaction reporting by community pharmacists\u2014the barriers and facilitators"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1002/pds.4800",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR7",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85074987580",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "28",
                                    "@issue": "12"
                                },
                                "pagerange": {
                                    "@first": "1552",
                                    "@last": "1559"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "M.L.",
                                    "@_fa": "true",
                                    "ce:surname": "Hughes",
                                    "ce:indexed-name": "Hughes M.L."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Weiss",
                                    "ce:indexed-name": "Weiss M."
                                }
                            ]},
                            "ref-sourcetitle": "Pharmacoepidemiol Drug Saf"
                        },
                        "ce:source-text": "Hughes ML, Weiss M. Adverse drug reaction reporting by community pharmacists\u2014the barriers and facilitators. Pharmacoepidemiol Drug Saf. 2019;28(12):1552\u20139. DOI: 10.1002/pds.4800"
                    },
                    {
                        "ref-fulltext": "Li R, et al. Community pharmacists\u2019 knowledge and perspectives of reporting adverse drug reactions in Australia: a cross-sectional survey. Int J Clin Pharm. 2018;40(4):878\u201389. DOI: 10.1007/s11096-018-0700-2",
                        "@id": "8",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Community pharmacists\u2019 knowledge and perspectives of reporting adverse drug reactions in Australia: a cross-sectional survey"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1007/s11096-018-0700-2",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR8",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85051841722",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "40",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "878",
                                    "@last": "889"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "R.",
                                    "@_fa": "true",
                                    "ce:surname": "Li",
                                    "ce:indexed-name": "Li R."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Int J Clin Pharm"
                        },
                        "ce:source-text": "Li R, et al. Community pharmacists\u2019 knowledge and perspectives of reporting adverse drug reactions in Australia: a cross-sectional survey. Int J Clin Pharm. 2018;40(4):878\u201389. DOI: 10.1007/s11096-018-0700-2"
                    },
                    {
                        "ref-fulltext": "Yu YM, et al. Patterns of adverse drug reactions in different age groups: analysis of spontaneous reports by community pharmacists. PLoS ONE. 2015;10(7):e0132916. DOI: 10.1371/journal.pone.0132916",
                        "@id": "9",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Patterns of adverse drug reactions in different age groups: analysis of spontaneous reports by community pharmacists"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1371/journal.pone.0132916",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR9",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "e0132916",
                                    "@idtype": "ARTNUM"
                                },
                                {
                                    "$": "84940760554",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"voliss": {
                                "@volume": "10",
                                "@issue": "7"
                            }},
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "Y.M.",
                                    "@_fa": "true",
                                    "ce:surname": "Yu",
                                    "ce:indexed-name": "Yu Y.M."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "PLoS ONE"
                        },
                        "ce:source-text": "Yu YM, et al. Patterns of adverse drug reactions in different age groups: analysis of spontaneous reports by community pharmacists. PLoS ONE. 2015;10(7):e0132916. DOI: 10.1371/journal.pone.0132916"
                    },
                    {
                        "ref-fulltext": "Elkalmi R, et al. Adverse drug reactions reporting: Knowledge and opinion of general public in Penang, Malaysia. J Pharm Bioallied Sci. 2013;5(3):224. DOI: 10.4103/0975-7406.116824",
                        "@id": "10",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Adverse drug reactions reporting: Knowledge and opinion of general public in Penang, Malaysia"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.4103/0975-7406.116824",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR10",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84883725792",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "5",
                                    "@issue": "3"
                                },
                                "pagerange": {"@first": "224"}
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "R.",
                                    "@_fa": "true",
                                    "ce:surname": "Elkalmi",
                                    "ce:indexed-name": "Elkalmi R."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Pharm Bioallied Sci"
                        },
                        "ce:source-text": "Elkalmi R, et al. Adverse drug reactions reporting: Knowledge and opinion of general public in Penang, Malaysia. J Pharm Bioallied Sci. 2013;5(3):224. DOI: 10.4103/0975-7406.116824"
                    },
                    {
                        "ref-fulltext": "Heath Product Vigilance Center, Report: Problems of health products vigilance in drug stores. 2003.",
                        "@id": "11",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2003"},
                            "ref-title": {"ref-titletext": "Report: Problems of health products vigilance in drug stores"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CR11",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85127049327",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-sourcetitle": "Heath Product Vigilance Center"
                        },
                        "ce:source-text": "Heath Product Vigilance Center, Report: Problems of health products vigilance in drug stores. 2003."
                    },
                    {
                        "ref-fulltext": "Thai FDA-Health Product Vigilance Center. Statistic of Adverse Events during 1984 - 2019. 2019; http://thaihpvc.fda.moph.go.th/thaihvc/Public/News/uploads/hpvc_5_13_0_100805.pdf. Accessed 1 Oct 2020.",
                        "@id": "12",
                        "ref-info": {
                            "ref-publicationyear": {
                                "@first": "1984",
                                "@last": "2019"
                            },
                            "ref-website": {"ce:e-address": {
                                "$": "http://thaihpvc.fda.moph.go.th/thaihvc/Public/News/uploads/hpvc_5_13_0_100805.pdf",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CR12",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85127068600",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-text": "Accessed 1 Oct 2020",
                            "ref-authors": {"collaboration": {
                                "@seq": "1",
                                "ce:text": "Thai FDA-Health Product Vigilance Center",
                                "ce:indexed-name": "Thai FDA-Health Product Vigilance Center"
                            }},
                            "ref-sourcetitle": "Statistic of Adverse Events during"
                        },
                        "ce:source-text": "Thai FDA-Health Product Vigilance Center. Statistic of Adverse Events during 1984 - 2019. 2019; http://thaihpvc.fda.moph.go.th/thaihvc/Public/News/uploads/hpvc_5_13_0_100805.pdf. Accessed 1 Oct 2020."
                    },
                    {
                        "ref-fulltext": "Guest G, Bunce A, Johnson L. How many interviews are enough? An experiment with data saturation and variability. Field Methods. 2006;18(1):59\u201382. DOI: 10.1177/1525822X05279903",
                        "@id": "13",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2006"},
                            "ref-title": {"ref-titletext": "How many interviews are enough? An experiment with data saturation and variability"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1177/1525822X05279903",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR13",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "33646698557",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "18",
                                    "@issue": "1"
                                },
                                "pagerange": {
                                    "@first": "59",
                                    "@last": "82"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "G.",
                                    "@_fa": "true",
                                    "ce:surname": "Guest",
                                    "ce:indexed-name": "Guest G."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Bunce",
                                    "ce:indexed-name": "Bunce A."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "L.",
                                    "@_fa": "true",
                                    "ce:surname": "Johnson",
                                    "ce:indexed-name": "Johnson L."
                                }
                            ]},
                            "ref-sourcetitle": "Field Methods"
                        },
                        "ce:source-text": "Guest G, Bunce A, Johnson L. How many interviews are enough? An experiment with data saturation and variability. Field Methods. 2006;18(1):59\u201382. DOI: 10.1177/1525822X05279903"
                    },
                    {
                        "ref-fulltext": "Mahmoud MA, et al. Community pharmacists\u2019 knowledge, behaviors and experiences about adverse drug reaction reporting in Saudi Arabia. Saudi Pharm J. 2014;22(5):411\u20138. DOI: 10.1016/j.jsps.2013.07.005",
                        "@id": "14",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Community pharmacists\u2019 knowledge, behaviors and experiences about adverse drug reaction reporting in Saudi Arabia"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/j.jsps.2013.07.005",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR14",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84920137305",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "22",
                                    "@issue": "5"
                                },
                                "pagerange": {
                                    "@first": "411",
                                    "@last": "418"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "M.A.",
                                    "@_fa": "true",
                                    "ce:surname": "Mahmoud",
                                    "ce:indexed-name": "Mahmoud M.A."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Saudi Pharm J"
                        },
                        "ce:source-text": "Mahmoud MA, et al. Community pharmacists\u2019 knowledge, behaviors and experiences about adverse drug reaction reporting in Saudi Arabia. Saudi Pharm J. 2014;22(5):411\u20138. DOI: 10.1016/j.jsps.2013.07.005"
                    },
                    {
                        "ref-fulltext": "Obara T, et al. Prevalence, determinants, and reasons for the non-reporting of adverse drug reactions by pharmacists in the Miyagi and Hokkaido regions of Japan. Adv Pharmacoepidemiol Drug Saf. 2015;4(191):2167\u20131052.",
                        "@id": "15",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Prevalence, determinants, and reasons for the non-reporting of adverse drug reactions by pharmacists in the Miyagi and Hokkaido regions of Japan"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CR15",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85050319117",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "4",
                                    "@issue": "191"
                                },
                                "pagerange": {
                                    "@first": "1052",
                                    "@last": "2167"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "T.",
                                    "@_fa": "true",
                                    "ce:surname": "Obara",
                                    "ce:indexed-name": "Obara T."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Adv Pharmacoepidemiol Drug Saf"
                        },
                        "ce:source-text": "Obara T, et al. Prevalence, determinants, and reasons for the non-reporting of adverse drug reactions by pharmacists in the Miyagi and Hokkaido regions of Japan. Adv Pharmacoepidemiol Drug Saf. 2015;4(191):2167\u20131052."
                    },
                    {
                        "ref-fulltext": "Qassim S, et al. Reporting adverse drug reactions: evaluation of knowledge, attitude and practice among community pharmacists in UAE. IOSR J Pharm. 2014;22(30):31\u201340.",
                        "@id": "16",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Reporting adverse drug reactions: evaluation of knowledge, attitude and practice among community pharmacists in UAE"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CR16",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84964383621",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "22",
                                    "@issue": "30"
                                },
                                "pagerange": {
                                    "@first": "31",
                                    "@last": "40"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Qassim",
                                    "ce:indexed-name": "Qassim S."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "IOSR J Pharm"
                        },
                        "ce:source-text": "Qassim S, et al. Reporting adverse drug reactions: evaluation of knowledge, attitude and practice among community pharmacists in UAE. IOSR J Pharm. 2014;22(30):31\u201340."
                    },
                    {
                        "ref-fulltext": "Duarte M, et al. Community pharmacists\u2019 attitudes towards adverse drug reaction reporting and their knowledge of the new pharmacovigilance legislation in the southern region of Portugal: a mixed methods study. Drugs Ther Persp. 2015;31(9):316\u201322. DOI: 10.1007/s40267-015-0227-8",
                        "@id": "17",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Community pharmacists\u2019 attitudes towards adverse drug reaction reporting and their knowledge of the new pharmacovigilance legislation in the southern region of Portugal: a mixed methods study"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1007/s40267-015-0227-8",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR17",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84940034307",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "31",
                                    "@issue": "9"
                                },
                                "pagerange": {
                                    "@first": "316",
                                    "@last": "322"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Duarte",
                                    "ce:indexed-name": "Duarte M."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Drugs Ther Persp"
                        },
                        "ce:source-text": "Duarte M, et al. Community pharmacists\u2019 attitudes towards adverse drug reaction reporting and their knowledge of the new pharmacovigilance legislation in the southern region of Portugal: a mixed methods study. Drugs Ther Persp. 2015;31(9):316\u201322. DOI: 10.1007/s40267-015-0227-8"
                    },
                    {
                        "ref-fulltext": "Khan TM. Community pharmacists\u2019 knowledge and perceptions about adverse drug reactions and barriers towards their reporting in Eastern region, Alahsa, Saudi Arabia. Ther Adv Drug Safety. 2013;4(2):45\u201351. DOI: 10.1177/2042098612474292",
                        "@id": "18",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Community pharmacists\u2019 knowledge and perceptions about adverse drug reactions and barriers towards their reporting in Eastern region, Alahsa, Saudi Arabia"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1177/2042098612474292",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR18",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84880396965",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "4",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "45",
                                    "@last": "51"
                                }
                            },
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "T.M.",
                                "@_fa": "true",
                                "ce:surname": "Khan",
                                "ce:indexed-name": "Khan T.M."
                            }]},
                            "ref-sourcetitle": "Ther Adv Drug Safety"
                        },
                        "ce:source-text": "Khan TM. Community pharmacists\u2019 knowledge and perceptions about adverse drug reactions and barriers towards their reporting in Eastern region, Alahsa, Saudi Arabia. Ther Adv Drug Safety. 2013;4(2):45\u201351. DOI: 10.1177/2042098612474292"
                    },
                    {
                        "ref-fulltext": "Irujo M, et al. Factors that influence under-reporting of suspected adverse drug reactions among community pharmacists in a Spanish region. Drug Saf. 2007;30(11):1073\u201382. DOI: 10.2165/00002018-200730110-00006",
                        "@id": "19",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2007"},
                            "ref-title": {"ref-titletext": "Factors that influence under-reporting of suspected adverse drug reactions among community pharmacists in a Spanish region"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.2165/00002018-200730110-00006",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR19",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "35649020853",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "30",
                                    "@issue": "11"
                                },
                                "pagerange": {
                                    "@first": "1073",
                                    "@last": "1082"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Irujo",
                                    "ce:indexed-name": "Irujo M."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Drug Saf"
                        },
                        "ce:source-text": "Irujo M, et al. Factors that influence under-reporting of suspected adverse drug reactions among community pharmacists in a Spanish region. Drug Saf. 2007;30(11):1073\u201382. DOI: 10.2165/00002018-200730110-00006"
                    },
                    {
                        "ref-fulltext": "Matos C, van Hunsel F, Joaquim J. Are consumers ready to take part in the Pharmacovigilance System?\u2014a Portuguese preliminary study concerning ADR reporting. Eur J Clin Pharmacol. 2015;71(7):883\u201390. DOI: 10.1007/s00228-015-1867-2",
                        "@id": "20",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Are consumers ready to take part in the Pharmacovigilance System?\u2014a Portuguese preliminary study concerning ADR reporting"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1007/s00228-015-1867-2",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR20",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84930867356",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "71",
                                    "@issue": "7"
                                },
                                "pagerange": {
                                    "@first": "883",
                                    "@last": "890"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "C.",
                                    "@_fa": "true",
                                    "ce:surname": "Matos",
                                    "ce:indexed-name": "Matos C."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "F.",
                                    "@_fa": "true",
                                    "ce:surname": "van Hunsel",
                                    "ce:indexed-name": "van Hunsel F."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Joaquim",
                                    "ce:indexed-name": "Joaquim J."
                                }
                            ]},
                            "ref-sourcetitle": "Eur J Clin Pharmacol"
                        },
                        "ce:source-text": "Matos C, van Hunsel F, Joaquim J. Are consumers ready to take part in the Pharmacovigilance System?\u2014a Portuguese preliminary study concerning ADR reporting. Eur J Clin Pharmacol. 2015;71(7):883\u201390. DOI: 10.1007/s00228-015-1867-2"
                    },
                    {
                        "ref-fulltext": "HÃ¤rmark L, et al. Patients\u2019 motives for participating in active post-marketing surveillance. Pharmacoepidemiol Drug Saf. 2013;22(1):70\u20136. DOI: 10.1002/pds.3327",
                        "@id": "21",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Patients\u2019 motives for participating in active post-marketing surveillance"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1002/pds.3327",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR21",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84872137143",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "22",
                                    "@issue": "1"
                                },
                                "pagerange": {
                                    "@first": "70",
                                    "@last": "76"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "L.",
                                    "@_fa": "true",
                                    "ce:surname": "HÃ¤rmark",
                                    "ce:indexed-name": "Harmark L."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Pharmacoepidemiol Drug Saf"
                        },
                        "ce:source-text": "HÃ¤rmark L, et al. Patients\u2019 motives for participating in active post-marketing surveillance. Pharmacoepidemiol Drug Saf. 2013;22(1):70\u20136. DOI: 10.1002/pds.3327"
                    },
                    {
                        "ref-fulltext": "Al Dweik R, et al. Factors affecting patient reporting of adverse drug reactions: a systematic review. Br J Clin Pharmacol. 2017;83(4):875\u201383. DOI: 10.1111/bcp.13159",
                        "@id": "22",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Factors affecting patient reporting of adverse drug reactions: a systematic review"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1111/bcp.13159",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR22",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85006483231",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "83",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "875",
                                    "@last": "883"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "R.",
                                    "@_fa": "true",
                                    "ce:surname": "Al Dweik",
                                    "ce:indexed-name": "Al Dweik R."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Br J Clin Pharmacol"
                        },
                        "ce:source-text": "Al Dweik R, et al. Factors affecting patient reporting of adverse drug reactions: a systematic review. Br J Clin Pharmacol. 2017;83(4):875\u201383. DOI: 10.1111/bcp.13159"
                    },
                    {
                        "ref-fulltext": "World Health Organization. Good Pharmacy Practice Joint FIP/WHO guidelines on GPP: Standards for quality of pharmacy service 2012. https://www.fip.org/file/1476. Accessed 1 Oct 2020.",
                        "@id": "23",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.fip.org/file/1476",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CR23",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84888869566",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-text": "Accessed 1 Oct 2020",
                            "ref-authors": {"collaboration": {
                                "@seq": "1",
                                "ce:text": "World Health Organization",
                                "ce:indexed-name": "World Health Organization"
                            }},
                            "ref-sourcetitle": "Good Pharmacy Practice Joint FIP/WHO guidelines on GPP: Standards for quality of pharmacy service"
                        },
                        "ce:source-text": "World Health Organization. Good Pharmacy Practice Joint FIP/WHO guidelines on GPP: Standards for quality of pharmacy service 2012. https://www.fip.org/file/1476. Accessed 1 Oct 2020."
                    },
                    {
                        "ref-fulltext": "Herdeiro MT, et al. Influence of pharmacists\u2019 attitudes on adverse drug reaction reporting. Drug Saf. 2006;29(4):331\u201340. DOI: 10.2165/00002018-200629040-00004",
                        "@id": "24",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2006"},
                            "ref-title": {"ref-titletext": "Influence of pharmacists\u2019 attitudes on adverse drug reaction reporting"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.2165/00002018-200629040-00004",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR24",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "33645462842",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "29",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "331",
                                    "@last": "340"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "M.T.",
                                    "@_fa": "true",
                                    "ce:surname": "Herdeiro",
                                    "ce:indexed-name": "Herdeiro M.T."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Drug Saf"
                        },
                        "ce:source-text": "Herdeiro MT, et al. Influence of pharmacists\u2019 attitudes on adverse drug reaction reporting. Drug Saf. 2006;29(4):331\u201340. DOI: 10.2165/00002018-200629040-00004"
                    }
                ]
            }}
        }
    },
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Iowa City",
            "@id": "60024324",
            "affilname": "University of Iowa",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60024324",
            "affiliation-country": "United States"
        }
    ],
    "coredata": {
        "srctype": "j",
        "prism:issueIdentifier": "1",
        "eid": "2-s2.0-85127065859",
        "dc:description": "Background: Adverse drug event (ADE) reporting is a significant process to increase consumer care and consumer safety associated with the use of medicines. An in-depth investigation into low ADE reporting by consumers and community pharmacists was undertaken to uncover interventions to improve reporting. Method: In-depth interviewing of the three parties; consumers, pharmacists and employees of the Pharmacovigilance Center in Thailand, was used to collect the data. They were interviewed about ADE reporting experiences and contributing factors and problems of ADE reporting. Thematic analysis was used to interpret the results. Result: The HPVC received few ADE reports from consumers. Most community pharmacists received ADE reports from consumers; however, the Pharmacovigilance Center received few ADE reports from community pharmacists. ADE reporting of community pharmacists and consumers were influenced by many factors which were categorized into four themes which were (1) \u201cCognition\u201d (awareness, attitude and responsibility); (2) \u201cReporting process\u201d (complication, competency, information deficiency, feedback, and resource); (3) \u201cInducer\u201d (service orientation, acquaintanceship, motivation, severity level, regulatory and reward); and (4) \u201cObstacle\u201d (doubt, belief and prosecution). Conclusion: Health professionals should motivate consumers to report ADEs. Building social responsibility and benefits and increasing knowledge of reporting process, channels, and system to both community pharmacists and consumers were recommended. Providing rewards and making community pharmacists feel comfortable to report ADEs by simplifying the ADE form and providing training, guidelines, and an ADR assessment tool can drive them to report ADEs. Feedback to consumers by confirming whether it was ADE and feedback to pharmacists that the Pharmacovigilance Center received their reports and their reports were utilized were also important.",
        "prism:coverDate": "2022-12-01",
        "prism:aggregationType": "Journal",
        "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/85127065859",
        "subtypeDescription": "Article",
        "dc:creator": {"author": [{
            "ce:given-name": "Tanattha",
            "preferred-name": {
                "ce:given-name": "Tanattha",
                "ce:initials": "T.",
                "ce:surname": "Kitisopee",
                "ce:indexed-name": "Kitisopee T."
            },
            "@seq": "1",
            "ce:initials": "T.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:surname": "Kitisopee",
            "@auid": "54889081900",
            "author-url": "https://api.elsevier.com/content/author/author_id/54889081900",
            "ce:indexed-name": "Kitisopee T."
        }]},
        "link": [
            {
                "@_fa": "true",
                "@rel": "self",
                "@href": "https://api.elsevier.com/content/abstract/scopus_id/85127065859"
            },
            {
                "@_fa": "true",
                "@rel": "scopus",
                "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85127065859&origin=inward"
            },
            {
                "@_fa": "true",
                "@rel": "scopus-citedby",
                "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85127065859&origin=inward"
            }
        ],
        "prism:publicationName": "Journal of Pharmaceutical Policy and Practice",
        "source-id": "21100325142",
        "citedby-count": "3",
        "prism:volume": "15",
        "subtype": "ar",
        "dc:title": "Consumers\u2019 adverse drug event reporting via community pharmacists: three stakeholder perception",
        "openaccess": "1",
        "openaccessFlag": "true",
        "prism:doi": "10.1186/s40545-022-00417-z",
        "prism:issn": "20523211",
        "publishercopyright": "Â© 2022, The Author(s).",
        "article-number": "19",
        "dc:identifier": "SCOPUS_ID:85127065859",
        "dc:publisher": "BioMed Central Ltd"
    },
    "idxterms": null,
    "language": {"@xml:lang": "eng"},
    "authkeywords": {"author-keyword": [
        {
            "@_fa": "true",
            "$": "Adverse drug event reporting"
        },
        {
            "@_fa": "true",
            "$": "Community pharmacists"
        },
        {
            "@_fa": "true",
            "$": "Consumers"
        },
        {
            "@_fa": "true",
            "$": "Pharmacovigilance center"
        },
        {
            "@_fa": "true",
            "$": "Stakeholder perception"
        }
    ]},
    "subject-areas": {"subject-area": [
        {
            "@_fa": "true",
            "$": "Pharmacy",
            "@code": "3611",
            "@abbrev": "HEAL"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology, Toxicology and Pharmaceutics (all)",
            "@code": "3000",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Health Policy",
            "@code": "2719",
            "@abbrev": "MEDI"
        }
    ]},
    "authors": {"author": [
        {
            "ce:given-name": "Tanattha",
            "preferred-name": {
                "ce:given-name": "Tanattha",
                "ce:initials": "T.",
                "ce:surname": "Kitisopee",
                "ce:indexed-name": "Kitisopee T."
            },
            "@seq": "1",
            "ce:initials": "T.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:surname": "Kitisopee",
            "@auid": "54889081900",
            "author-url": "https://api.elsevier.com/content/author/author_id/54889081900",
            "ce:indexed-name": "Kitisopee T."
        },
        {
            "ce:given-name": "Jirunya",
            "preferred-name": {
                "ce:given-name": "Jirunya",
                "ce:initials": "J.",
                "ce:surname": "Assanee",
                "ce:indexed-name": "Assanee J."
            },
            "@seq": "2",
            "ce:initials": "J.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:surname": "Assanee",
            "@auid": "57223977897",
            "author-url": "https://api.elsevier.com/content/author/author_id/57223977897",
            "ce:indexed-name": "Assanee J."
        },
        {
            "ce:given-name": "Bernard A.",
            "preferred-name": {
                "ce:given-name": "Bernard A.",
                "ce:initials": "B.A.",
                "ce:surname": "Sorofman",
                "ce:indexed-name": "Sorofman B.A."
            },
            "@seq": "3",
            "ce:initials": "B.A.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60024324",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60024324"
            },
            "ce:surname": "Sorofman",
            "@auid": "6603710987",
            "author-url": "https://api.elsevier.com/content/author/author_id/6603710987",
            "ce:indexed-name": "Sorofman B.A."
        },
        {
            "ce:given-name": "Suntaree",
            "preferred-name": {
                "ce:given-name": "Suntaree",
                "ce:initials": "S.",
                "ce:surname": "Watcharadmrongkun",
                "ce:indexed-name": "Watcharadmrongkun S."
            },
            "@seq": "4",
            "ce:initials": "S.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:surname": "Watcharadmrongkun",
            "@auid": "57550027800",
            "author-url": "https://api.elsevier.com/content/author/author_id/57550027800",
            "ce:indexed-name": "Watcharadmrongkun S."
        }
    ]}
}}